New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 12, 2013
08:08 EDTBEATBioTelemetry announces newly published research on cost savings with MCT
BioTelemetry announced that recently published research from an observational study of more than 200,000 patients demonstrates significant in-hospital cost savings in the twelve months following diagnosis using mobile cardiac telemetry, or MCT. A retrospective analysis was completed on claims data spanning 57 months and more than 200,000 patients to compare diagnostic efficacy, therapeutic outcomes and cardiovascular costs incurred in the hospital setting for patients diagnosed with MCT, Holter and event devices. Results published in Medical Device: Evidence and Research demonstrate a significantly higher diagnostic yield in patients utilizing MCT, at 61%, compared to event, at 23%, and Holter, at 24%. Therapeutic intervention measured through the prescription of antiarrhythmic drugs was also substantially higher in patients monitored with MCT, at 61%, compared to event, at 39%, and Holter, at 43%. The study's most significant finding was the level of cost savings per patient in cardiovascular in-hospital costs when an MCT is used versus either an event or Holter monitor. The study shows that the substitution of the MCT for an event or Holter monitor provides a 10 to 15 times return on investment in the first 12 months post-utilization.
News For BEAT From The Last 14 Days
Check below for free stories on BEAT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BEAT

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use